229 related articles for article (PubMed ID: 26016809)
41. Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.
Wu L; Han X; Jiang X; Ding H; Qi C; Yin Z; Xiao J; Xiong L; Guo Q; Ye Z; Qu B; Shen N
Front Immunol; 2021; 12():747616. PubMed ID: 34745118
[TBL] [Abstract][Full Text] [Related]
42. The role of IFI35 in lupus nephritis and related mechanisms.
Zhang L; Zhu H; Li Y; Dai X; Zhou B; Li Q; Zuo X; Luo H
Mod Rheumatol; 2017 Nov; 27(6):1010-1018. PubMed ID: 28064541
[TBL] [Abstract][Full Text] [Related]
43. Elevated expression of miR-21 and miR-155 in peripheral blood mononuclear cells as potential biomarkers for lupus nephritis.
Khoshmirsafa M; Kianmehr N; Falak R; Mowla SJ; Seif F; Mirzaei B; Valizadeh M; Shekarabi M
Int J Rheum Dis; 2019 Mar; 22(3):458-467. PubMed ID: 30398001
[TBL] [Abstract][Full Text] [Related]
44. The role of miR-146b-5p in TLR4 pathway of glomerular mesangial cells with lupus nephritis.
Sheng ZX; Yao H; Cai ZY
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1737-1743. PubMed ID: 29630120
[TBL] [Abstract][Full Text] [Related]
45. Mesangial cells of lupus-prone mice are sensitive to chemokine production.
Ka SM; Cheng CW; Shui HA; Wu WM; Chang DM; Lin YC; Chen A
Arthritis Res Ther; 2007; 9(4):R67. PubMed ID: 17617918
[TBL] [Abstract][Full Text] [Related]
46. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.
Avihingsanon Y; Phumesin P; Benjachat T; Akkasilpa S; Kittikowit V; Praditpornsilpa K; Wongpiyabavorn J; Eiam-Ong S; Hemachudha T; Tungsanga K; Hirankarn N
Kidney Int; 2006 Feb; 69(4):747-53. PubMed ID: 16518330
[TBL] [Abstract][Full Text] [Related]
47. Involvement of TWEAK and the NF-κB signaling pathway in lupus nephritis.
Sun F; Teng J; Yu P; Li W; Chang J; Xu H
Exp Ther Med; 2018 Mar; 15(3):2611-2619. PubMed ID: 29456665
[TBL] [Abstract][Full Text] [Related]
48. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC
Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456
[TBL] [Abstract][Full Text] [Related]
49. Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis.
Perez-Hernandez J; Martinez-Arroyo O; Ortega A; Galera M; Solis-Salguero MA; Chaves FJ; Redon J; Forner MJ; Cortes R
J Nephrol; 2021 Aug; 34(4):1157-1167. PubMed ID: 32803682
[TBL] [Abstract][Full Text] [Related]
50. High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers of Kidney Damage in Patients with Systemic Lupus Erythematosus.
Navarro-Quiroz E; Pacheco-Lugo L; Lorenzi H; Díaz-Olmos Y; Almendrales L; Rico E; Navarro R; España-Puccini P; Iglesias A; Egea E; Aroca G
PLoS One; 2016; 11(11):e0166202. PubMed ID: 27835701
[TBL] [Abstract][Full Text] [Related]
51. Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis.
Soliman S; Mohamed FA; Ismail FM; Stanley S; Saxena R; Mohan C
Int J Rheum Dis; 2017 Nov; 20(11):1714-1727. PubMed ID: 29076253
[TBL] [Abstract][Full Text] [Related]
52. Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis.
Nakhjavani M; Etemadi J; Pourlak T; Mirhosaini Z; Zununi Vahed S; Abediazar S
Iran J Kidney Dis; 2019 May; 13(3):198-206. PubMed ID: 31209193
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-183 exerts a protective role in lupus nephritis through blunting the activation of TGF-β/Smad/TLR3 pathway via reducing Tgfbr1.
Qi H; Cao Q; Liu Q
Exp Cell Res; 2020 Sep; 394(2):112138. PubMed ID: 32535034
[TBL] [Abstract][Full Text] [Related]
54. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
55. MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.
Tu Y; Guo R; Li J; Wang S; Leng L; Deng J; Bucala R; Lu L
Front Immunol; 2019; 10():2229. PubMed ID: 31608058
[No Abstract] [Full Text] [Related]
56. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration.
Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H
Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247
[TBL] [Abstract][Full Text] [Related]
57. A novel potential target of IL-35-regulated JAK/STAT signaling pathway in lupus nephritis.
Cai Z; Zhang S; Wu P; Ren Q; Wei P; Hong M; Feng Y; Wong CK; Tang H; Zeng H
Clin Transl Med; 2021 Feb; 11(2):e309. PubMed ID: 33634995
[TBL] [Abstract][Full Text] [Related]
58. Knockdown of TRIM27 expression suppresses the dysfunction of mesangial cells in lupus nephritis by FoxO1 pathway.
Liu J; Feng X; Tian Y; Wang K; Gao F; Yang L; Li H; Tian Y; Yang R; Zhao L; Miao X; Huang J; Liu Q; Zhang W; Li Y; Wang C; Duan H; Liu S
J Cell Physiol; 2019 Jul; 234(7):11555-11566. PubMed ID: 30648253
[TBL] [Abstract][Full Text] [Related]
59. Can measuring urinary biomarkers improve the management of lupus nephritis?
Rahman A
Arthritis Res Ther; 2012 Dec; 14(6):127. PubMed ID: 23256781
[TBL] [Abstract][Full Text] [Related]
60. Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus.
Yuan Y; Yang M; Wang K; Sun J; Song L; Diao X; Jiang Z; Cheng G; Wang X
Arthritis Res Ther; 2017 Mar; 19(1):70. PubMed ID: 28356164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
